Description générale
Dolutegravir is an integrase inhibitor indicated for the treatment of HIV infection.
INN
Dolutegravir
Codes ATC
Type de médicament
Chemical agent
Historique des statuts LME
Ajouté pour la première fois en 2017
(TRS
1006)
pour
Human immunodeficiency virus disease without mention of associated disease or condition, clinical stage unspecified
Wikipédia
DrugBank
Recommandations
Section
Antiretrovirals > Integrase inhibitors
- Oral > Solid: 50 mg tablet; 10 mg tablet (dispersible, scored)